Sean E. Bland, JD, reviews the USPSTF guidelines as support to access HIV PrEP therapy and Ryan Bitton, PharmD, MBA, shares a payer perspective on the implications of these guidelines. Ryan Haumschild ...
Please provide your email address to receive an email when new articles are posted on . The recommendation is consistent with the task force’s 2022 draft and 2019 final recommendations. Risk factors ...
Carl Schmid and Frank J. Palella, MD, discuss how coverage differs for medications vs ancillary service costs for HIV PrEP based on USPSTF guidelines. Ryan Haumschild, PharmD, MS, MBA: I’m going to ...
A new Canadian guideline on HIV prevention emphasizes the patient’s role in decisions related to pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) prescriptions. It also highlighted ...
Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated Canadian guideline published in CMAJ (Canadian Medical Association Journal) ...
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
Oral HIV pre-exposure prophylaxis (PrEP) is highly effective for preventing HIV. Several different developments in the US either threaten to increase or promise to decrease PrEP out-of-pocket costs ...
1don MSN
Georgia bill would allow pharmacists to prescribe PrEP in effort to expand HIV prevention access
A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that ...
World Health Organisation (WHO) has released new guidelines for the use of long-acting cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV. Director of WHO’s Global HIV, Hepatitis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results